Background: The time course of mild cardiotoxicity induced by anthracycline remains unknown. The aim of this study was to evaluate the long-term evolution of decreased myocardial reserve in children previously treated with a cumulative dose of anthracycline up to 100mg/m 2. Patients and Methods: Twenty-seven asymptomatic cancer survival patients (25 with lymphoblastic leukemia), in continuous remission and off treatment for >12 months with no alterations in conventional echocardiograms were evaluated by exercise echocardiography at 37±15.4 months (T1) and 101±24 months (T2) after finishing treatment (ADRIA group). This group was compared with 25 healthy individuals (control group) similar to the ADRIA group with respect to age and body surf...
The goal of this study was to evaluate late cardiotoxic effects of anthracyclines (ATC) by evaluatin...
Background: Childhood cancer survivors (CCSs) have an increased risk of morbidity and mortality. We ...
Background: Introducing anthracycline antibiotics into the treatment of children's malignancies cont...
Doppler echocardiography has been used for the diagnosis of anthracycline-induced cardiotoxicity. Ho...
Background. Exercise echocardiography reveals abnormalities in asymptomatic childhood cancer survivo...
ObjectiveSurvivors of childhood cancer treated with anthracyclines carry the risk for developing lat...
Introduction Late cardiotoxicity is a known complication of anthracycline therapy but the long-term ...
PURPOSE: Echocardiographic surveillance for asymptomatic left ventricular systolic dysfunction (ALVS...
International audienceBackground: This study aimed to detect late sub-clinical patterns of cardiac d...
There are over 270,000 childhood cancer survivors in the US. Of these survivors, more than 50% have ...
Anthracyclines, which are effective in the treatment of childhood cancer, are known for their cardio...
Anthracycline-induced cardiotoxicity can lead to clinical and subclinical heart failure. Decrease of...
Background: Cardiotoxicity is one of the most serious chronic complications of anthracyclines therap...
Ongoing research in the field of pediatric oncology has led to an increased number of childhood canc...
Pediatric cancer patients who receive anthracycline chemotherapy are at risk for developing cardiac ...
The goal of this study was to evaluate late cardiotoxic effects of anthracyclines (ATC) by evaluatin...
Background: Childhood cancer survivors (CCSs) have an increased risk of morbidity and mortality. We ...
Background: Introducing anthracycline antibiotics into the treatment of children's malignancies cont...
Doppler echocardiography has been used for the diagnosis of anthracycline-induced cardiotoxicity. Ho...
Background. Exercise echocardiography reveals abnormalities in asymptomatic childhood cancer survivo...
ObjectiveSurvivors of childhood cancer treated with anthracyclines carry the risk for developing lat...
Introduction Late cardiotoxicity is a known complication of anthracycline therapy but the long-term ...
PURPOSE: Echocardiographic surveillance for asymptomatic left ventricular systolic dysfunction (ALVS...
International audienceBackground: This study aimed to detect late sub-clinical patterns of cardiac d...
There are over 270,000 childhood cancer survivors in the US. Of these survivors, more than 50% have ...
Anthracyclines, which are effective in the treatment of childhood cancer, are known for their cardio...
Anthracycline-induced cardiotoxicity can lead to clinical and subclinical heart failure. Decrease of...
Background: Cardiotoxicity is one of the most serious chronic complications of anthracyclines therap...
Ongoing research in the field of pediatric oncology has led to an increased number of childhood canc...
Pediatric cancer patients who receive anthracycline chemotherapy are at risk for developing cardiac ...
The goal of this study was to evaluate late cardiotoxic effects of anthracyclines (ATC) by evaluatin...
Background: Childhood cancer survivors (CCSs) have an increased risk of morbidity and mortality. We ...
Background: Introducing anthracycline antibiotics into the treatment of children's malignancies cont...